Stay updated with breaking news from Jong Wook Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first-in-class oral factor D inhibitor danicopan (Voydeya) has been approved for the management of extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH).
LONDON (dpa-AFX) - AstraZeneca Plc (AZN.L, AZN) said on Friday that its ALPHA phase III trial has met the primary endpoint and key secondary endpoints.The ALPHA phase III trial is evaluating the